Table 1 Characteristics, redox status, CD26-expression and muscle fatigue parameters of ME/CFS patients and control subjects
ME/CFS (n = 32) | Controls (n = 11) | |
|---|---|---|
Age (years) | 42 ± 7 | 46 ± 5 |
Sex ratio (F/M) | 24/12 | 6/5 |
ME/CFS duration (y) | 5 ± 1 | |
At rest | ||
RAA/TBARS | 91 ± 19* | 129 ± 15 |
CD26-expression (AU) | 2.72 + 0.09* | 3.60 ± 0.09 |
End exercise | ||
VO2max (ml min−1 kg−1) | 23 ± 1 | 26 ± 4 |
Δ M-wave (%) | −41 ± 8** | +8 ± 6 |
ΔTBARS (%) | +50 ± 10** | +15 ± 7 |